Insiders Trades

★ Sign in to follow

MW

Matthew W. Towse

CFO

US·SEC (Form 4)

NxStage Medical, Inc.

Cumul. flow

Total declarations

48

Company

1

▲ Purchases (0 ops.)

—

▼ Sales (18 ops.)

€1.6M

Latest filing published 25 Feb 2019 for NxStage Medical, Inc., €751k.

Filing timeline

BuySale

Matthew W. Towse

Insider track record

Disclosed buys

0

Disclosed sells

18

Signal history

Matthew W. Towse: trading record in brief

Matthew W. Towse appears in our data through filings on NxStage Medical, Inc. shares, published by SEC (Form 4). We count 48 filings; the first trade dates from 15 July 2013 and the latest from 21 February 2019.

On the market, this insider has only sold: 18 sales, €1.6M in total. The rest of the record consists of 9 share grants and 20 option exercises.

The latest filing, published on 25 February 2019, reports a transaction of €751k in NxStage Medical, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Matthew W. Towse

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

NxStage Medical, Inc. (US)

Declarations48 total

●

Matthew W. Towse

SVP and Chief Financial OfficeExecutives21 Feb 2019NxStage Medical, Inc.

851,880 USD27SEC

28,396 shares@ US$30.0092.1% of flowCommon StockSEC:0001246360-19-000766:0

◇

Matthew W. Towse

SVP and Chief Financial OfficeExecutives9 Mar 2018NxStage Medical, Inc.

0SEC

5,821 shares0Common StockSEC:0001246360-18-001073:0

◆

Matthew W. Towse

SVP and Chief Financial OfficeExecutives9 Mar 2018NxStage Medical, Inc.

44,987 USD19SEC

1,846 shares@ US$24.371.3% of flowCommon StockSEC:0001246360-18-001073:1

◇

Matthew W. Towse

SVP and Chief Financial OfficeExecutives20 Oct 2017NxStage Medical, Inc.

56,622 USD19SEC

4,030 shares@ US$14.051.7% of flowCommon StockSEC:0001246360-17-002926:0

▼

Matthew W. Towse

SVP and Chief Financial OfficeExecutives20 Oct 2017NxStage Medical, Inc.

110,825 USD34SEC

4,030 shares@ US$27.503.2% of flowCommon StockSEC:0001246360-17-002926:1

◇

Matthew W. Towse

SVP and Chief Financial OfficeExecutives20 Sept 2017NxStage Medical, Inc.

60,415 USD19SEC

4,300 shares@ US$14.051.8% of flowCommon StockSEC:0001246360-17-002802:0

▼

Matthew W. Towse

SVP and Chief Financial OfficeExecutives20 Sept 2017NxStage Medical, Inc.

117,261 USD34SEC

4,300 shares@ US$27.273.4% of flowCommon StockSEC:0001246360-17-002802:1

◇

Matthew W. Towse

SVP and Chief Financial OfficeExecutives21 Aug 2017NxStage Medical, Inc.

60,415 USD19SEC

4,300 shares@ US$14.051.8% of flowCommon StockSEC:0001246360-17-002622:0

▼

Matthew W. Towse

SVP and Chief Financial OfficeExecutives21 Aug 2017NxStage Medical, Inc.

125,646 USD34SEC

4,300 shares@ US$29.223.7% of flowCommon StockSEC:0001246360-17-002622:1

◇

Matthew W. Towse

SVP and Chief Financial OfficeExecutives20 Jul 2017NxStage Medical, Inc.

60,415 USD19SEC

4,300 shares@ US$14.051.8% of flowCommon StockSEC:0001246360-17-002418:0

▼

Matthew W. Towse

SVP and Chief Financial OfficeExecutives20 Jul 2017NxStage Medical, Inc.

103,888 USD34SEC

4,300 shares@ US$24.163.1% of flowCommon StockSEC:0001246360-17-002418:1

◆

Matthew W. Towse

SVP and Chief Financial OfficeExecutives15 Jul 2017NxStage Medical, Inc.

22,240 USD19SEC

916 shares@ US$24.280.7% of flowCommon StockSEC:0001246360-17-002357:0

◇

Matthew W. Towse

SVP and Chief Financial OfficeExecutives20 Jun 2017NxStage Medical, Inc.

60,415 USD19SEC

4,300 shares@ US$14.051.9% of flowCommon StockSEC:0001246360-17-002232:0

▼

Matthew W. Towse

SVP and Chief Financial OfficeExecutives20 Jun 2017NxStage Medical, Inc.

100,147 USD34SEC

4,300 shares@ US$23.293.1% of flowCommon StockSEC:0001246360-17-002232:1

◇

Matthew W. Towse

SVP and Chief Financial OfficeExecutives22 May 2017NxStage Medical, Inc.

60,415 USD19SEC

4,300 shares@ US$14.051.9% of flowCommon StockSEC:0001246360-17-001996:0

▼

Matthew W. Towse

SVP and Chief Financial OfficeExecutives22 May 2017NxStage Medical, Inc.

91,848 USD34SEC

4,300 shares@ US$21.362.8% of flowCommon StockSEC:0001246360-17-001996:1

◇

Matthew W. Towse

SVP and Chief Financial OfficeExecutives20 Apr 2017NxStage Medical, Inc.

60,415 USD19SEC

4,300 shares@ US$14.052.0% of flowCommon StockSEC:0001246360-17-001631:0

▼

Matthew W. Towse

SVP and Chief Financial OfficeExecutives20 Apr 2017NxStage Medical, Inc.

117,304 USD37SEC

4,300 shares@ US$27.283.8% of flowCommon StockSEC:0001246360-17-001631:1

◇

Matthew W. Towse

SVP and Chief Financial OfficeExecutives20 Mar 2017NxStage Medical, Inc.

60,415 USD19SEC

4,300 shares@ US$14.052.0% of flowCommon StockSEC:0001246360-17-001435:0

▼

Matthew W. Towse

SVP and Chief Financial OfficeExecutives20 Mar 2017NxStage Medical, Inc.

118,938 USD37SEC

4,300 shares@ US$27.663.8% of flowCommon StockSEC:0001246360-17-001435:1

◆

Matthew W. Towse

SVP and Chief Financial OfficeExecutives3 Mar 2017NxStage Medical, Inc.

89,205 USD19SEC

3,151 shares@ US$28.312.9% of flowCommon StockSEC:0001246360-17-001206:1

◇

Matthew W. Towse

SVP and Chief Financial OfficeExecutives3 Mar 2017NxStage Medical, Inc.

0SEC

9,747 shares0Common StockSEC:0001246360-17-001206:0

◇

Matthew W. Towse

SVP and Chief Financial OfficeExecutives21 Feb 2017NxStage Medical, Inc.

60,415 USD19SEC

4,300 shares@ US$14.052.0% of flowCommon StockSEC:0001246360-17-000951:0

▼

Matthew W. Towse

SVP and Chief Financial OfficeExecutives21 Feb 2017NxStage Medical, Inc.

125,818 USD37SEC

4,300 shares@ US$29.264.1% of flowCommon StockSEC:0001246360-17-000951:1

◇

Matthew W. Towse

SVP and Chief Financial OfficeExecutives20 Jan 2017NxStage Medical, Inc.

60,415 USD19SEC

4,300 shares@ US$14.052.0% of flowCommon StockSEC:0001246360-17-000248:0

25 of 48 declarations